Pregnancy Prediction Using Anti-Müllerian Hormone in Intrauterine Insemination Cycles

Jose Antonio Moreno

Status: Completed

Conditions: Anti-Mullerian Hormone Deficiency; Infertility, Female

Treatments: Procedure: Intrauterine insemination

Study type: Observational

Funder types: Other

Identifiers

NCT06263192

AMH-IUI

Details and patient eligibility

About

The goal of this study is to compare the cumulative pregnancy rates after 4 artificial inseminations with donor (IAD) in non-sterile women with plasma AMH levels > and < 1.1 ng/mL.

Enrollment: 342 patients

Sex: Female

Ages: 25 to 39 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• IUI cycles with sperm donors either due to severe oligoasthenoteratozoospermia in the partner (defined as a motile sperm count (MSC) < 5 million in the ejaculate) or for social reasons, with up to 4 attempts accounted for.

Exclusion criteria

• BMI >30
• Infertility due to bilateral tubal factor
• Endometriosis grade II-IV.

Trial design

342 participants in 2 patient groups

AMH < 1.1 ng/ml

Treatment:

Procedure: Intrauterine insemination

AMH > 1.1 ng/ml

Treatment:

Procedure: Intrauterine insemination